𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CIITA versus IFN-γ induced MHC class II expression in head and neck cancer cells

✍ Scribed by Markus Meissner; Theresa L. Whiteside; Roland Kaufmann; Barbara Seliger

Book ID
106078900
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
323 KB
Volume
301
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant glioma cells use MHC class II
Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation
✍ Jeanne M. Soos; Jeffrey I. Krieger; Olaf Stüve; Chelsea L. King; Juan Carlos Pat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Malignant gliomas (MGs), lethal human central nervous system (CNS) neoplasms, contain tumor infiltrating lymphocytes (TIL). Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4^+^ T cells, deficienci

RB and A novel E2F-1 binding protein in
RB and A novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-γ induction of the class II transactivator ciita in class II non-inducible RB-defective tumor lines
✍ Michael E. Tschickardt; Yanmei Lu; Mark Jacim; G. de Wayne Ussery; Viktor Steiml 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 611 KB

The major histocompatibility (MHC) class II genes encode cell surface proteins that bind antigenic peptide for presentation to T-cells. The class II proteins are expressed constitutively on B-cells and EBV-transformed B-cells, and are inducible by IFN-y on a wide variety of cell types. Retinoblastom